
The UK’s National Institute for Health Research (NIHR) has awarded a £135,000 grant to gaitQ, a spin-off from the University …

Newron Pharmaceuticals and its partner Zambon have announced an agreement for a potentially pivotal study to evaluate the efficacy of …

AbbVie has landed an option to buy neurodegenerative disease-focused biotech Mitokinin following completion of investigational new drug (IND)-enabling studies on …

A new study is set to go ahead that will test if ondansetron is safe and effective in treating Parkinson’s …

Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …

A surprising find has led researchers to see that a drug used to treat enlarged prostates may also work as …

It’s Friday, and time for another run-down of the week’s most popular articles.

Patients with Parkinson’s have been able to walk after receiving electrical stimulation to their spines. A new treatment, developed by …

The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …

A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified methods to prevent neurodegeneration …